Manhattan Scientifics, Inc.
MHTX
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 9.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 9.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 0.00 | 9.00K |
| SG&A Expenses | 673.00K | 696.00K | 693.00K | 714.00K | 712.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 683.00K | 709.00K | 703.00K | 726.00K | 723.00K |
| Operating Income | -683.00K | -709.00K | -703.00K | -726.00K | -714.00K |
| Income Before Tax | -1.06M | -1.13M | -1.17M | -1.31M | -1.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.06 | -1.13 | -1.17 | -1.31 | -1.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.06M | -1.13M | -1.17M | -1.31M | -1.12M |
| EBIT | -683.00K | -709.00K | -703.00K | -726.00K | -714.00K |
| EBITDA | -682.60K | -708.30K | -701.80K | -723.80K | -711.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.24B | 2.24B | 2.24B | 2.24B | 2.24B |
| Average Diluted Shares Outstanding | 2.24B | 2.24B | 2.24B | 2.24B | 2.24B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
